Literature DB >> 8960911

Minimal phenotype panels. A method for achieving maximum population coverage with a minimum of HLA antigens.

R F Schipper1, C A van Els, J D'Amaro, M Oudshoorn.   

Abstract

Vaccination with peptides that induce a specific immune response is a potential prophylactic or therapeutic strategy against viral infections and tumors. Because of the extensive polymorphism of the HLA loci, synthetic peptide vaccines must consist of a cocktail of peptides that bind specifically to different HLA molecules. Such cocktails should be optimized for the target population as each population has its specific HLA gene frequencies. To achieve maximum population coverage with a minimum number of peptides, information is needed on the ranking of the most frequent HLA phenotypes. We introduce the minimal phenotype panel, which is the smallest combination of HLA antigens selected so that the proportion of individuals in a population that express at least one of the antigens in the panel exceeds a desired minimum value. We developed a method for assembling minimal phenotype panels based on known HLA class I gene frequencies. We give an example based on a set of 2446 well-defined HLA-typed, random, healthy, unrelated, Dutch Caucasoid individuals. In addition, we discuss the possibility of assembling minimal phenotype panels based on two-locus haplotypes, which enables the assembly of phenotype panels from the antigens of both loci.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8960911     DOI: 10.1016/s0198-8859(96)00138-3

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  8 in total

1.  The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapy.

Authors:  Simon Walz; Juliane S Stickel; Daniel Johannes Kowalewski; Heiko Schuster; Katja Weisel; Linus Backert; Stefan Kahn; Annika Nelde; Tatjana Stroh; Martin Handel; Oliver Kohlbacher; Lothar Kanz; Helmut Rainer Salih; Hans-Georg Rammensee; Stefan Stevanović
Journal:  Blood       Date:  2015-07-02       Impact factor: 22.113

2.  HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL).

Authors:  Daniel J Kowalewski; Heiko Schuster; Linus Backert; Claudia Berlin; Stefan Kahn; Lothar Kanz; Helmut R Salih; Hans-Georg Rammensee; Stefan Stevanovic; Juliane Sarah Stickel
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-29       Impact factor: 11.205

3.  Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1.

Authors:  Jianming Tang; Shenghui Tang; Elena Lobashevsky; Angela D Myracle; Ulgen Fideli; Grace Aldrovandi; Susan Allen; Rosemary Musonda; Richard A Kaslow
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

4.  Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin.

Authors:  Katherine A Richards; Francisco A Chaves; Frederick R Krafcik; David J Topham; Christopher A Lazarski; Andrea J Sant
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

5.  Elicitation from virus-naive individuals of cytotoxic T lymphocytes directed against conserved HIV-1 epitopes.

Authors:  Pedro A Reche; Derin B Keskin; Rebecca E Hussey; Petronela Ancuta; Dana Gabuzda; Ellis L Reinherz
Journal:  Med Immunol       Date:  2006-05-18

6.  Identification of HLA-A*2402-restricted HCMV immediate early-1 (IE-1) epitopes as targets for CD8+ HCMV-specific cytotoxic T lymphocytes.

Authors:  Jong-Baeck Lim; Hyun Ok Kim; Seok Hoon Jeong; Joo Eun Ha; Sunphil Jang; Sang-Guk Lee; Kyungwon Lee; David Stroncek
Journal:  J Transl Med       Date:  2009-08-23       Impact factor: 5.531

7.  Short-term in-vitro expansion improves monitoring and allows affordable generation of virus-specific T-cells against several viruses for a broad clinical application.

Authors:  René Geyeregger; Christine Freimüller; Stefan Stevanovic; Julia Stemberger; Gabor Mester; Jasmin Dmytrus; Thomas Lion; Hans-Georg Rammensee; Gottfried Fischer; Britta Eiz-Vesper; Anita Lawitschka; Susanne Matthes; Gerhard Fritsch
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

8.  Predicting population coverage of T-cell epitope-based diagnostics and vaccines.

Authors:  Huynh-Hoa Bui; John Sidney; Kenny Dinh; Scott Southwood; Mark J Newman; Alessandro Sette
Journal:  BMC Bioinformatics       Date:  2006-03-17       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.